Pharma
Page: 2
Why dengue in Europe could spell disaster for the rest of the world
What single market? Why Romanians get new medicines 2 years after Germans
Weight loss drugs: Fake Ozempic and Wegovy surge in Europe
The Joint Procurement Agreement: driving EU health solidarity
Pharma, agri companies face threat of EU ban on some ‘forever chemicals’
Novo Nordisk’s weight loss drug launches in UK
Novo Nordisk’s weight-loss drug cuts heart failure symptoms
People treated with Wegovy had reduced physical limitations from heart failure and improved exercise function, the company said.
Why Big Pharma might think twice about running away to America
A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.
The curious case of Schrödinger’s text messages
Did Ursula von der Leyen exchange text messages with Pfizer’s CEO? The Commission still isn’t telling.
Germany on track to bin 200M COVID-19 vaccine doses
The total waste is likely to run into the billions of euros.
Transforming everyday health, one app at a time
Readmission rates drop and clinical capacity can nearly double thanks to digital disease self-management tools.
EU buys vaccine capacity to prepare for next pandemic
The contract secures 325M vaccine doses a year in case of an emergency.
Uncommon but affecting millions: the rare disease paradox
Thirty million people affected by rare diseases live among us in Europe. How can the EU stimulate research and innovation to help rare disease patients?
Pharma reform: Patients can’t afford to wait. Act now.
Waiting five years to try and fix patient access while we watch EU competitiveness decline is not the solution.
Secrecy around von der Leyen’s vaccine texts hurting EU reputation, say campaigners
Activists say the lack of transparency is ‘chipping away at public trust.’
After a 70-year wait, will Europe’s new patent system be a total flop?
The unitary patent system launches on Thursday but more than 400,000 patents have been opted out.
Danish conservative MEP deselected over bullying complaints
The lawmaker has recently been appointed as Parliament’s lead negotiator on the pharmaceutical directive.
Pfizer, the EU, and disappearing ink
The European Commission has systematically blocked scrutiny of its COVID-19 vaccine deal with Pfizer. This week’s update to the contract is no different.
EU and Pfizer renegotiate controversial vaccine contract
Central and Eastern European countries have clamored to revise the terms of the deal.
Rare diseases: Little known disease has big impact on patients, families and society
What is transfusion-dependent beta thalassemia and how could we improve the lives of those impacted?
How countries are throwing away their best chance to prevent the next pandemic
Negotiations on a global pandemic treaty are on course to the lowest common denominator.
Happy pills: How Sweden and Denmark became rare bright spots for Europe’s pharma industry
While in most of Europe the sector is in a funk, the two Northern European countries are bucking the trend.
EU capitals propose Chips Act for medicines
Countries are concerned by the concentration of pharmaceutical production in China.
Poland calls out Pfizer over vaccine glut
Health Minister Adam Niedzielski calls on pharma giant to come to more favorable terms in negotiations with EU.
EU pharma reform: Winners and losers
The Commission has published its first major overhaul to the bloc’s medicines regulations in 20 years.
Big Pharma meets its match as EU refuses to budge
Proposed legislation contains a punishing new measure that will cut into the sector’s bottom line.